SLC6A3 and Parkinson disease: As it has been shown that limb rigidity in patients with PD points to sensorimotor processing damage resulting from a change in their descending monoaminergic inhibitory control [42], we sought to determine the effect of a pro-parkinsonian neurotoxin on the diencephalospinal pathway despite the absence of DAT expression.